CooperSurgical, a part of
The Cooper Companies
), a company focused on contact lens and women's health, recently
revealed the launch of its Carter-Thomason II Port Closure
System. This system allows rapid and safe closure of port sites
for obese to regular patients going through a variety of
laparoscopic operations. It has two constituent parts, namely the
Suture Guide and the sophisticated Suture Passer.
COOPER COS (COO): Free Stock Analysis Report
JOHNSON & JOHNS (JNJ): Free Stock Analysis
NOVARTIS AG-ADR (NVS): Free Stock Analysis
To read this article on Zacks.com click here.
The Suture Guide ensures total closure including for peritoneum
and fascia. This methodology preserves the pneumoperitoneum and
allows precise positioning of the Suture Passer for steady
outcomes with each closure.
The latest Suture Passer comes with a new and improved design
with extended and retractable fingers. It permits doctors to
implement over a larger area for safer and faster recovery of
sutures in the abdomen.
The Carter-Thomason II Port Closure System permits accurate
closure of fascia for a range of patients, ranging from average
to those with morbid obesity. This prevents the occurrence of
herniation at point of port location, which is a possible
complication arising from minimally invasive procedures.
Cooper is a global medical products company specializing in a
wide range of contact lenses for the vision correction market
with a smaller strategic business unit for women's health. It
reportedly holds the number three position in the $6 billion
global contact lens industry.
The outlook for the contact lens industry is favorable. Cooper
has significant market share in high growth specialty lenses.
The company is a leader in the high-margin toric lens market. It
offers multiple designs of toric lenses across a wide range of
parameters, unlike some of its competitors, who offer toric
lenses in a limited number of designs.
However, Cooper faces formidable competition in each of its major
product lines. Competition comes from well established global
contact lens makers such as
Johnson & Johnson
). Depressed levels of consumer spending have heightened the
competitive pressures on the company.
Our Outperform recommendation is supported by a short-term Zacks
#2 Rank (Buy).